Study of a new tablet for treating migraine attacks in adults
Part of Brain & nervous system clinical trials.
This trial tests an investigational tablet called BR005-036C for quickly treating migraine attacks in adults. If you have frequent migraines but not too many headache days overall, you might be able to join and help see if this new medicine is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with migraine (with or without aura) for at least 1 year, and your migraines must have started before age 50.
- You must have had 2 to 8 moderate-to-severe migraine attacks per month in the last 3 months.
- You must have fewer than 15 headache days per month (including non-migraine headaches).
- You should not have certain rare headache types or serious health conditions (like heart or liver disease), and you must not have had certain cancer within the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication to treat migraine attacks in adults who get them regularly. It might reduce the number of attacks and improve your quality of life.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This study tests an investigational medication called NB001 for treating migraine attacks as they happen. If you have frequent migraines, this treatment might help reduce the severity or shorten the duration of your attacks.
This trial is testing new ways to treat migraine attacks. It is for adults in Denmark who have migraine on a few days each month and have used triptan rescue medicines.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This trial tests a new medicine, MEDI0618, against a placebo for people with episodic migraine. The goal is to see if MEDI0618 is safe and effective at reducing migraine days.
Hear when a new Migraine, With or Without Aura trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.